P rostate cancer (PC) is the most common cancer in men and the second most common cause of death. Radiation therapy (RT) is frequently used in all stages of PC, from the early, organ-confined stage to advanced metastatic disease. High doses of RT (Ͼ70 Gy) are required to eradicate even early cancer, and such doses can lead to acute and/or chronic side effects such as urethritis, proctitis, and erectile dysfunction, due to irradiation of the neighboring structures. Persistence of local disease after radiation is a significant issue in the management of this disease, as there remains a continuing potential for symptomatic local recurrence or metastatic seeding. A method of increasing the intrinsic radiosensitivity of the PC cells may allow eradication of the cancer with lower doses of RT, with a resultant decrease in the side effects and improved quality of life.
Ataxia telangiectasia (AT) is an autosomal recessive cancer-prone disorder that is characterized by pleiotropic phenotype including progressive cerebellar ataxia, neuronal degeneration, telangiectasia, hypogonadism, growth retardation, immune deficiency, and extreme hypersensitivity to ionizing radiation (IR). 1, 2 The AT gene product, AT mutated (ATM), is a large 370-kDa protein that contains a COOH-terminal domain (ϳ400 residues) homologous to the catalytic subunits of phosphatidylinositol 3-kinases (PI-3Ks). 3 This protein encodes a protein kinase activity specific for serine and threonine residues (reviewed in Ref. 4) . Disruption of the atm gene in mice produced many features of the AT phenotype, including exquisite sensitivity to low doses of IR. 4, 5 Recent studies have shown that ATM activates key regulators of multiple signal transduction pathways and mediates efficient induction of the signaling network responsible for cell-cycle arrest and repair of IR-induced DNA damage, resulting in cellular recovery and survival after exposure to IR (reviewed in Ref. 6 ). For example, IR promotes stabilization of the p53 protein and induces a p53-dependent G 1 "checkpoint" that requires ATM. This is mediated by the phosphorylation of p53 by ATM kinase at serine-15 residue, which in turn inhibits the interaction of p53 with Mdm2, leading to stabilization of the p53 protein. 7, 8 Cell lines with dysfunctional ATM, when irradiated, either show a lack of or delayed activation of p53, 9 -11 resulting in a defective G 1 /S cell-cycle checkpoint. In p53 mutated cell lines, disruption of ATM resulted in retarded cell proliferation, defective G 2 /M checkpoint control, radio-resistant DNA synthesis, and enhanced radiosensitivity.
in PC cells would increase their intrinsic radiosensitivity, possibly by disrupting the protective signal transduction machinery that promotes cell survival after exposure to IR. The hypersensitivity to IR associated with ATM dysfunction is cell-type specific and has a diverse relationship with the status of the p53 gene expression. In addition, genetic alterations of p53 have been associated with persistent disease in PC patients, 13 with tumor progression 14 after RT, and with hormone-refractory, metastatic PC. 15, 16 Therefore, we examined whether attenuation of ATM function after antisense atm gene therapy would result in enhanced radiosensitivity in a hormone-refractory, p53-mutant PC cell line, PC-3.
MATERIALS AND METHODS

Construction of the recombinant antisense ATM adenovirus
A schematic drawing of the adenoviral shuttle plasmids that were used to construct the recombinant viruses is shown in Figure 1 . Briefly, cDNA fragments containing either the translational start domain (188 -445 bp), the PI-3K domain (8167-8854 bp), or both of these domains of the ATM gene were subcloned in an antisense orientation into the adenovirus shuttle vector pAC-CMV (a gift from Dr. Glen Fishman, Mt. Sinai Medical Center, New York, NY). ATM start domain cDNA was amplified by reverse transcriptase polymerase chain reaction (PCR) with the primers U2-GAAATTA TG AA CCATGAG (188 -206 bp of ATM open reading frame (ORF)) and L2-TGGTTTT GCT AT TC TCAG (427-445 bp of ATM ORF) from total RNA extracted from a human glioma cell line, U-87 MG. The amplified start domain was initially cloned into PCR 3.1 plasmid (Invitrogen, Carlsbad, Calif) and subsequently excised by EcoRI and inserted into the corresponding EcoRI site in the pAC-CMV shuttle plasmid. Plasmids were screened to obtain a clone with the start domain in an antisense orientation from the cytomegalovirus (CMV) promoter and were verified by DNA sequencing. A 688-bp BglII-SalI fragment (8167-8854 bp of ATM ORF), containing the PI-3K domain, was subcloned from the pGEM-ATM14 plasmid and inserted into the BamHI-SalI site of the pAC-CMV shuttle plasmid in an antisense orientation from the CMV promoter. To construct the shuttle vector carrying both of the antisense domains, the simian virus 40 splice and early polyadenylation (poly(A)) signal fragment were excised from the pAC vector and inserted between the start antisense domain and the existing poly(A) signal of the pAC antisense ATM plasmid. The CMV promoter ATM PI-3K cassette was then excised from the pAC-CMV antisense atm PI-3K plasmid and inserted between the two poly(A) cassettes to generate pAC antisense ATM start/PI-3K shuttle plasmid. The antisense orientation of the ATM cDNA domains in the shuttle plasmids was confirmed by restriction enzyme mapping and DNA sequencing. The antisense ATM shuttle plasmids were then cotransfected with pJM17 into 293 cells, using Lipofectamine Plus reagent (Life Technologies, Grand Island, NY) according to the manufacturer's protocol. Replication-defective adenoviruses were obtained by homologous recombination. 17, 18 The adenoviral lysates from individual plaques were screened for antisense ATM by PCR amplification using an upstream primer from the CMV promoter region (5Ј-CACCAAAAT CAA C GGGAC-3Ј) and downstream primers from the ATM start domain (primer U2) and ATM PI-3K domain (5Ј-GGTTGAGAAG CG ATTGG-3Ј (8734 -8751 bp of ATM ORF), respectively. After plaque purification, virus growth, titration, and purification (by CsCl step gradient) were performed as described previously. 19 The adenovirus containing ␤-galactosidase (␤-gal) (ad5-CMV ␤-gal) was a gift from Dr. J. Roy-Chowdhury (Albert Einstein College of Medicine, New York, NY). The infection efficiency was determined by the method described previously. 20 Briefly, PC-3 cells (10 4 ) were seeded in 35-mm tissue culture plates; different concentrations of Ad5-CMV-␤-gal were added for 5 hours, and the cells were then washed with culture medium and incubated for 24 hours. Next, cells were fixed with 2% formaldehyde and 0.05% glutaraldehyde for 5 minutes at room temperature. The cells were washed twice with phosphate-buffered saline (PBS) and stained in 5-bromo-4-chloro-3-indolyl ␤-D-galactoside, 2 mM MgCl 2 , and 5 mM potassium ferrocyanide (1 mg/mL) at 37°C overnight. The cells were then washed with PBS. Individual dark blue cells were counted to estimate the adenoviral infectivity in PC-3 cells.
Cell culture
The established androgen-independent, p53-mutant, human PC cell line, PC-3, was obtained from the American Type Culture Collection (Manassas, Va). Cells were cultured as a monolayer in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf sera and 1% penicillin and streptomycin at 37°C in a humidified environment of 95% air and 5% CO 2 .
Electrophoresis and immunoblotting
Immunoblotting was performed using a standard procedure. 21 At various timepoints after adenoviral infection of PC-3 cells, the cells were collected and washed three times with ice-cold PBS, followed by lysis using lysis buffer containing proteinase inhibitors (50 mM tris(hydroxymethyl)aminomethane-Cl (pH 7.5), 100 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 3 g/mL leupeptin, and 1 L/mL aprotinin). Protein concentrations in cell lysates were determined using the Bio-Rad protein assay (Bio-Rad, Richmond, Calif). To detect ATM (molecular mass of 370 kDa) expression, 50 g of cell lysates were loaded on sodium dodecyl sulfate/5% polyacrylamide gel, electrophoresed, and transferred to a polyvinylidenedifluoride membrane (Millipore, Bedford, Mass) in a Transblot apparatus (BioRad). To detect ␤-actin (molecular mass of 42 kDa) expression, equal amounts of protein (50 g) were electrophoresed on a 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel. Equal protein loading was monitored by staining with Poinceau solution (Sigma, St. Louis, Mo). Membranes were probed with polyclonal anti-ATM antibody (Ab) (H248, amino acids 2830 -3056; Santa Cruz Biotechnology, Santa Cruz, Calif) at a concentration of 2 g/mL, or with anti-actin Ab (Oncogene Science, Gaithersburg, Md) for 2 hours. The membranes were then incubated with horseradish peroxidaseconjugated anti-rabbit immunoglobulin G (1:2000; Amersham, Arlington Heights, Ill) or with anti-mouse immunoglobulin M (1:10000), followed by development with enhanced chemiluminescence (ECL Plus ; Amersham). The immunoblots were scanned with a molecular imager (model GS-363; Bio-Rad) and the density of the bands for ATM was normalized to ␤-actin by densitometric analysis.
Radiation procedure
PC-3 cells were irradiated in a rotating vertical column using a cesium 137 IBL 437c irradiator (CISBIO, Saclay, France) at a dose rate of 9.1 Gy/minute and were immediately returned to a CO 2 incubator at 37°C.
Cell-cycle/proliferation assays
Exponentially growing cells were irradiated (3 Gy) at 48 hours after adenoviral infection and pulse-labeled thereafter for 1 hour in 30 M 5-bromodeoxyuridine (BrdU). Cells were trypsinized, and the pellet was fixed in iced 70% ethanol for 20 minutes and stored at Ϫ20°C for fluorescence-activated cell sorter analysis. Cell pellets were rehydrated by washing with PBS containing 0.5% bovine serum albumin (BSA), and the cells were resuspended in 2 M HCl with 0.5% BSA, incubated in room temperature for 20 minutes, and washed with PBS with 0.5% BSA. The residual acid was neutralized with 0.1 M sodium borate. BrdU staining was performed with 1:1 diluted, fluorescein-conjugated, anti-BrdU monoclonal Ab (PharMingen, San Diego, Calif), as per the manufacturer's instructions. For simultaneous analysis of DNA synthesis and cell cycle, after BrdU staining and washing, the cells were treated with 50 U of ribonuclease (Sigma) at 37°C for 15 minutes and counterstained with propidium iodide (25 g/mL; Boehringer Mannheim, Indianapolis, Ind) for 30 minutes. The cells were placed on ice and immediately subjected to flow cytometric analysis, for quantification of DNA content and BrdU incorporation, on a FACScan (Becton Dickinson, Mountain View, Calif) using CellQuest software (Becton Dickinson, San Jose, Calif) and WinMidi shareware (J. Trotter, Scripps Clinic, La Jolla, Calif).
Growth rate assay
Exponentially growing cells were infected with Ad-CMV-␤-gal or antisense Ad-ATM-start/PI-3K adenoviruses at a multiplicity of infection (MOI) of 100. At 48 hours after viral infection, the cells were irradiated and replated at a density of 10 4 cells/well in 6-well plates in triplicate. Cells from each group were trypsinized (24 -96 hours after IR), washed, and counted in a hemocytometer for absolute cell number to ascertain the growth rate.
Clonogenic assay
PC-3 cells were infected with various adenoviruses (Ad-CMV-␤-gal, Ad-antisense ATM start domain, Ad-antisense ATM PI-3K domain, or Ad-antisense ATM start and PI-3K domain) at a MOI of 100 for 5 hours. Preliminary experiments showed that attenuation of ATM protein expression was maximal by 48 hours. The cells were plated in triplicate at limiting dilutions in 6-well plates 48 hours after adenoviral infection. After 16 hours, they were irradiated (0 -6 Gy) and incubated for 2-3 weeks at 37°C. Before counting the colonies, the culture medium was decanted and the cells were fixed in 10% formalin, rinsed, and stained with 1.0% crystal violet in citric acid. Plating efficiencies for the three cell lines were similar and ranged from 20% to 35% between successive experiments. Colonies containing Ͼ50 cells were counted as survivor colonies, and surviving fractions were always normalized to the plating efficiency.
RESULTS
Generation of recombinant adenoviruses
The adenoviral shuttle plasmids containing the antisense ATM start domain, antisense ATM PI-3K domain, or antisense ATM start/PI-3K domain are shown in Figure  1 . The presence of recombinant adenovirus in the viral stocks and in infected PC-3 cells was confirmed by PCR amplification of viral DNA using an upstream primer from the CMV promoter and a downstream primer from the antisense-ATM domains. A 0.32-kb, 0.21-kb, or 1.61-kb fragment could be amplified from cellular DNA extracted from cells infected with antisense ATM adenoviral vectors, adeno-start, adeno-PI-3K, and adeno-start/ PI-3K, respectively, with no corresponding bands de-FAN, CHAKRAVARTY, ALFIERI, ET AL: ANTISENSE ATM GENE THERAPY FOR PROSTATE CANCER tected in either 293 cells or wild-type PC-3 cells (Fig 2) . An 80% efficiency of viral infection was achieved at a MOI of 100 for PC-3 cells as determined by the expression of ␤-gal activity. Because the recombinant virus used for these studies was defective in replication, distribution of ␤-gal activity corresponds directly to the efficiency of the initial infection.
Attenuation of ATM protein expression
Expression of ATM protein was analyzed by immunoblotting using an Ab to the carboxyl terminus of human ATM at different timepoints after adenovirus infection. As shown in Figure 3A , the amount of ATM protein was markedly reduced in PC-3 cells infected with the three different atm antisense adenoviruses. The adenovirus expressing antisense RNA to the both start and PI-3K domains of the atm gene had the most dramatic effect on depletion of the ATM protein. Results obtained from this study indicated that a decrease in ATM protein level could be detected at 24 hours postinfection, and this decrease reached a nadir at 2 days and was sustained for up to 4 days (Fig 3B) . The amount of ATM protein returned to normal values after 5 days of infection. This could be due to the presence of adenoviral episomal DNA, which does not replicate as the PC-3 cells divide, resulting in fewer cells expressing the antisense ATM transcript. Because adeno-anti-ATM-start/PI-3K virus showed maximal attenuation of the ATM protein, we performed additional experiments with this virus.
Aberrant cell-cycle control in antisense ATMtransduced PC-3 cells after irradiation AT cells display defective cell-cycle checkpoint control after exposure to IR. One characteristic phenotype of AT cells is radioresistant DNA synthesis, which is defined as a failure of AT cells to halt DNA replication after irradiation. Therefore, we examined whether antisense ATM gene transduction results in aberrant cellcycle checkpoint control in PC-3 cells. Ad-anti-ATMstart/PI-3K-infected PC-3 cells were incubated with BrdU during pulse-labeling after irradiation with 3 Gy. Parental and ad-␤-gal-infected cells exhibited S-phase arrest, with a decrease in BrdU-positive S-phase cells (58.5 Ϯ 5% and 55.4 Ϯ 10% in untreated and ad-␤-galtreated PC-3 cells, respectively) 24 hours after irradiation (Fig 4A and B) . In contrast, irradiated PC-3 cells infected with adeno-anti-ATM-start/PI-3K domains had a 22 Ϯ 9% decrease in BrdU-positive cells (Fig 4, A and  B) . This finding suggests that the disruption of ATM protein expression with antisense ATM results in defective S-phase cell-cycle checkpoint control in response to IR.
Radiation sensitivity
The effects of adeno-antisense ATM on the growth of PC-3 cells were determined before and after irradiation with a clinically relevant dose fraction of 2 Gy. The infected and noninfected PC-3 cells grew at a similar rate before irradiation. The cell number was significantly reduced (P Ͻ .0005) in the adeno-anti-ATM-start/PI-3K-infected group after 2 Gy of irradiation compared with the PC-3 cells infected with adeno-␤-gal (Fig 5) .
A clonogenic assay was performed and colony formation was measured after irradiation to determine whether attenuation of ATM resulted in a radiosensitive phenotype. The clonogenic capacity of PC-3 cells was examined by infecting them with adeno-␤-gal, adenoanti-ATM-start domain, adeno-anti-ATM-PI-3K domain, and adeno-anti-ATM-start/PI-3K domain at a MOI of 100 plaque-forming units/cell. The cells were irradiated (2, 4, and 6 Gy) at 48 hours after viral infection. Plating efficiencies were based on unirradiated controls. The clonogenic survival curves of representative parental cells, ad-␤-gal-infected PC-3 cells, and ad-anti-ATM-start/PI-3K-infected PC-3 cells are shown in Figure 6A . The fraction of parental and ad-␤-galinfected PC-3 cells surviving a radiation exposure of 2 Gy (SF2), the most commonly used dose fraction for external beam radiation treatment of localized carcinoma of the prostate, was 0.65 and 0.60, respectively. In contrast, the SF2s of antisense ATM-infected PC-3 cells were significantly lowered to 0.34, 0.28, and 0.25 for adeno-anti-ATM-start, adeno-anti-ATM-PI-3K, and adeno-anti-ATM-start/PI-3K, respectively (Fig 6B) , demonstrating a significant increase in radiosensitivity.
DISCUSSION
RT has been a primary treatment option for organconfined PC. Persistence of PC cells after RT may be the source of symptomatic local recurrence and distant metastasis. Therefore, to achieve local control, higher doses of irradiation (Ͼ70 Gy) are required that may result in significant toxicity to adjacent normal tissues, such as the rectum and bladder. Recent evidence suggests that mutations in the p53 gene have been associated with radiation failures, 13 metastatic progression, 14 and hormone refractivity. 15 Our experiments, therefore, 
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targeted the radioprotective signal transduction machinery of an irradiated, p53-null, hormone-independent PC cell line. 20 In contrast to previous attempts to improve radiotherapy by use of pharmacological radiosensitizers, genetic radiosensitization does not depend upon the hypothesis of a minority cell population of hypoxic cells being the principal obstacle to radiocurability, but aims to sensitize all tumor cells sharing a common genetic or phenotypic feature. Here we demonstrate for the first time that PC cells, when infected with an adenovirus expressing antisense RNA to the translational start and PI-3K domains of the ATM gene, can attenuate ATM protein expression, resulting in aberrant cell-cycle checkpoint control and reduced clonogenic survival of irradiated tumor cells.
Damage to cellular DNA evokes a wide range of cellular responses that lead to activation of a variety of genes necessary for cellular survival, delay in cell-cycle progression, and induction of DNA repair. ATM is a key mediator of the radioprotective machinery that induces a signaling network that is responsible for repair of IR-induced damaged DNA and for cellular recovery and survival. Thus, ectopic expression of full-length ATM cDNA reverses the defective cell-cycle checkpoint control and the exquisite radiosensitivity of AT cells. 22 The carboxyl terminal PI-3K domain of the ATM gene appears to be essential for cell survival after irradiation, as expression of this domain could reverse the radiosensitivity of a human colorectal carcinoma cell line that expresses a dominant-negative ATM mutant. 23 Genetic radiosensitizing strategies using dominant-negative mutants, such as overexpression of the ATM leucine zipper domain, could have "bystander" effects on the function of other leucine zipper proteins. In contrast, the genetic antisense method directly targets nucleotide homologies and might interfere with the transcription and/or translation of the ATM gene specifically. It was reported recently that an antisense construct of full-length ATM cDNA imposes a radiosensitive phenotype on normal cells. 24 As most common gene transfer vectors, such as adenoviral vectors, have a limitation in the amount of foreign DNA sequences that can be added, we chose to identify specific domains of the ATM gene for antisensemediated attenuation of ATM protein expression and function. Previous strategies using a retroviral antisense RNA to the PI-3K catalytic domain of the ATM gene imposed radiosensitivity to a human glioma cell line. 25 We now demonstrate that attenuation of ATM protein expression was achieved in PC-3 cells after infection with an adenoviral vector expressing antisense RNA to either the translational start domain, the PI-3K domain ATM antisense, or both (Fig 3) . The antisense ATM-infected PC-3 cells exhibited many features of ATM cells, such as radioresistant DNA synthesis and increased radiosensitivity. When exposed to IR, most replicating cells delay progression through the cell cycle via activation of cell-cycle checkpoints. The DNA damage-triggered checkpoints may activate repair of damaged DNA and help to ensure fidelity in DNA template replication and mitotic chromosome segregation. Without checkpoint control, AT cells proceed through the cell cycle despite DNA damage, and continue with DNA replication, resulting in enhanced chromosomal aberrations and reduced clonogenic survival after exposure to IR. In these experiments, PC-3 cells infected with the recombinant antisense ATM adenoviruses showed an inability to activate the S-phase checkpoint after RT.
The intrinsic radiosensitivity of human tumors is quantitatively expressed as the survival fraction after a clinically relevant 2-Gy dose (SF2). The SF2s of most common PC cell lines average around 0.56. 26 In contrast, lymphomas that are characteristically sensitive to RT have SF2s that are often Ͻ0. 35 . 27 Our experiments demonstrate that ATM attenuation by antisense ATM gene therapy resulted in a lowering of the SF2 of PC-3 cells from 0.60 to 0.25. This could translate to an enormous therapeutic benefit where fractionated RT in 2-Gy fractions could be effective in achieving higher local tumor control with less normal tissue morbidity.
Adenovirus-mediated gene transfer has high infection efficiency in a wide range of host cells and is clinically attractive. PC cells grow slowly and are characterized by higher potential doubling time. 28 Thus, other viral gene transfer strategies that infect only replicating cells, such as retroviruses, may be inefficient for gene therapy of PC cells. Another advantage of combining adenovirus gene therapy with radiation is that irradiation itself has been reported to markedly increase the efficiency of adenovirus gene transfer. 29 For potential clinical application, nonreplicating adenoviruses expressing antisense ATM RNA can be safely delivered only to the prostate by the transperineal route, which is frequently used during prostate brachytherapy. In addition, the lack of a diffusible toxic product, common to suicide gene therapy approaches, 30 -32 would limit the potential bystander normal tissue toxicities. Thus, antisense ATM gene therapy could serve as an adjuvant to RT by targeting the intrinsic radioprotective mechanisms of PC cells.
